5261 - 5270 of 6257 Results
Title
Year
- Development and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson’s Disease2025OPENTitle: Development and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson’s DiseaseJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-025-00771-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-025-00771-5.pdfCitation Count: 0
- Impact of clinical neurophysiological assessment on diagnosis and management of tremor disorders2025OPENTitle: Impact of clinical neurophysiological assessment on diagnosis and management of tremor disordersJournal Name: Clinical Neurophysiology PracticePublisher: Elsevier BVVol: 10Issue #:Start Page: 188End Page: 201Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cnp.2025.05.003Best OA location URL: https://doi.org/10.1016/j.cnp.2025.05.003Citation Count: 0
- Exploring the intersection between orthostatic hypotension and daytime sleepiness in Parkinson's disease2024OPENTitle: Exploring the intersection between orthostatic hypotension and daytime sleepiness in Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 468Issue #:Start Page: 123366End Page: 123366Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2024.123366Citation Count: 4
-
OPENTitle: Replication and reliability of Parkinson's disease clinical subtypesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 124Issue #:Start Page: 107016End Page: 107016Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107016Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11590651Citation Count: 1
-
OPENTitle: Nigral volume loss in prodromal, early, and moderate Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00976-3Best OA location URL: https://www.nature.com/articles/s41531-025-00976-3.pdfCitation Count: 0
- Postsynaptic adaptations in direct pathway muscarinic M4-receptor signaling follow the temporal and regional pattern of dopaminergic degeneration2025OPENTitle: Postsynaptic adaptations in direct pathway muscarinic M4-receptor signaling follow the temporal and regional pattern of dopaminergic degenerationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01047-3Best OA location URL: https://doi.org/10.1038/s41531-025-01047-3Citation Count: 0
- Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials2025OPENTitle: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trialsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01041-9Best OA location URL: https://www.nature.com/articles/s41531-025-01041-9.pdfCitation Count: 0
- Dopamine and cortical neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunction2025OPENTitle: Dopamine and cortical neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunctionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01048-2Best OA location URL: https://www.nature.com/articles/s41531-025-01048-2.pdfCitation Count: 0
- The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging2025OPENTitle: The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 31Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-025-03834-0Best OA location URL: https://www.nature.com/articles/s41591-025-03834-0.pdfCitation Count: 0
- Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer’s Disease2025OPENTitle: Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer’s DiseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-025-63564-2Best OA location URL: https://www.nature.com/articles/s41467-025-63564-2.pdfCitation Count: 0